I-GSK ibhengeza inyathelo elikhulu eliya kumabhongo ozinzo ngokuqhubela phambili kwenkqubo ye-carbon Ventolin ephantsi ukuya kulingo lweSigaba sesi-III.
I-GSK namhlanje ibhengeze ukuba iya kuqalisa iimvavanyo zeSigaba sesi-III soguqulelo lwekhabhoni ephantsi ye-inhaler yayo yemitha (MDI), iVentolin (salbutamol), isebenzisa isizukulwana esilandelayo, ngo-2024.. Ukuba iphumelele, inamandla okunciphisa ukukhutshwa kwegesi ye-greenhouse ekusetyenzisweni kwe-inhaler malunga ne-90%, inegalelo elibonakalayo ekujoliswe kuko kwemozulu ye-GSK ye-net-zero.
Izigulana ezizizigidi ezingamashumi amathathu anesihlanu ezineemeko zokuphefumla kwihlabathi liphela zixhomekeke kwesi siphefumli njengeyeza lokuhlangula. Nangona kunjalo, i-akhawunti malunga nesiqingatha (49%) ye-GSK ye-carbon footprint kwaye igalelo kwi-carbon footprint yeenkqubo zempilo zehlabathi. Ukunciphisa ngokuphawulekayo i-carbon footprint ye-propellant kwi-inhaler yinto ephambili kwindlela yenkampani kwi-net-zero.
Funda ngokugqithisileyo kule link